ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) - ANVISA Registration 10345162065

Access comprehensive regulatory information for ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345162065 and manufactured by SIEMENS HEALTHCARE DIAGNOSITCS INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ABBOTT GMBH, BIO - RAD LABORATORIES INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.